Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation

被引：0
作者：
Grisetti, Luca [1 ,2 ]
Saponaro, Anna Alessia [1 ,2 ]
Sukowati, Caecilia [1 ,3 ]
Bonazza, Deborah [4 ]
Giacomello, Emiliana [5 ]
Tarchi, Paola [6 ]
Croce, Lory Saveria [1 ,5 ,7 ]
Palmisano, Silvia [5 ,7 ]
Anfuso, Beatrice [8 ]
Rosso, Natalia [1 ]
Giraudi, Pablo [1 ]
Tiribelli, Claudio [1 ]
Pascut, Devis [1 ]
机构：
[1] Fdn Italiana Fegato ONLUS, Trieste, Italy
[2] Univ Trieste, Dept Life Sci, Trieste, Italy
[3] Natl Res & Innovat Agcy Indonesia BRIN, Eijkman Res Ctr Mol Biol, Jakarta, Indonesia
[4] ASUGI, Surg Pathol, Trieste, Italy
[5] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
[6] ASUGI, Surg Clin, Trieste, Italy
[7] ASUGI, Liver Pathol Clin, Trieste, Italy
[8] ICGEB, Trieste, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-516-YI
引用
收藏
页码：S429 / S430
页数：2
相关论文
共 50 条
  • [21] Expression of programmed death ligand-1 and programmed death 1 in hepatocellular carcinoma and its clinical significance
    Long, J.
    Qu, Tao
    Pan, X. F.
    Tang, X.
    Wan, H. H.
    Qiu, P.
    Xu, Yan-Hua
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S1188 - S1192
  • [22] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
  • [23] Increased expression of programmed death-ligand 1 (PD-L1) on infiltrating immune cells of hepatocellular carcinoma (HCC) tissues after sorafenib treatment
    Lu, Li-Chun
    Lee, Yi-Hsuan
    Chang, Chun-Jung
    Shao, Yu-Yun
    Liu, Tsung-hao
    Cheng, Ann-Lii
    Hsu, Chih-Hung
    CANCER RESEARCH, 2017, 77
  • [24] Programmed Death-1 Expression in Micropapillary Urothelial Carcinoma of the Bladder: Role for Immune Checkpoint Inhibitors
    Goodman, Abigail L.
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2017, 97 : 227A - 227A
  • [25] Programmed Death-1 Expression in Micropapillary Urothelial Carcinoma of the Bladder: Role for Immune Checkpoint Inhibitors
    Goodman, Abigail L.
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2017, 30 : 227A - 227A
  • [26] Salmonella Breaks Tumor Immune Tolerance by Downregulating Tumor Programmed Death-Ligand 1 Expression
    Chen, Man-Chin
    Pangilinan, Christian Ronquillo
    Lee, Che-Hsin
    CANCERS, 2020, 12 (01)
  • [27] MECHANISMS OF THE SYNERGISTIC EFFECT OF IFN-G AND IL-1β ON INCREASING PROGRAMMED DEATH-LIGAND 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA
    Numata, Yasunao
    Akutsu, Noriyuki
    Ishigami, Keisuke
    Koide, Hideyuki
    Wagatsuma, Kohei
    Motoya, Masayo
    Sasaki, Shigeru
    Nakase, Hiroshi
    GASTROENTEROLOGY, 2022, 162 (07) : S1184 - S1185
  • [28] The possibility of programmed death-ligand 1-related immune modulation in neoadjuvant thermoradiotherapy for rectal cancer
    You, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S1194 - S1194
  • [29] First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population
    Zhang, Feiyang
    Chen, Guoming
    Yin, Yixin
    Chen, Xiaojiang
    Nie, Runcong
    Chen, Yingbo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [30] Transarterial chemoembolisation enhances programmed death-1 and programmed death ligand-1 expression in hepatocellular carcinoma
    Montasser, A.
    Beaufrere, A.
    Cauchy, F.
    Soubrane, O.
    Colnot, N.
    Tessiore, S.
    Albuquerque, M.
    Paradis, V.
    VIRCHOWS ARCHIV, 2019, 475 : S20 - S20
12345